{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:48:16Z","timestamp":1790704096688,"version":"4.1.0"},"reference-count":197,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"am","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ajogmf.2020.100159","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:46:45Z","timestamp":1592873205000},"page":"100159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"S","title":["Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019"],"prefix":"10.1016","volume":"2","author":[{"given":"Margaux","family":"Louchet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Sibiude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Picone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Tr\u00e9luyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-7597","authenticated-orcid":false,"given":"Laurent","family":"Mandelbrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2020.100159_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajog.2020.03.021","article-title":"Coronavirus disease 2019 (COVID-19) pandemic and pregnancy","volume":"222","author":"Dashraath","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2020.02.017","article-title":"Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know","volume":"222","author":"Rasmussen","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/v12020194","article-title":"Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections","volume":"12","author":"Schwartz","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ajogmf.2020.100159_bib5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib6","doi-asserted-by":"crossref","first-page":"104447","DOI":"10.1016\/j.jcv.2020.104447","article-title":"Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2","volume":"128","author":"Egloff","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","article-title":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2020.100159_bib8","doi-asserted-by":"crossref","DOI":"10.5858\/arpa.2020-0901-SA","article-title":"An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes","author":"Schwartz","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib9","first-page":"418","article-title":"[Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases]","volume":"49","author":"Chen","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.ajogmf.2020.100159_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4868","article-title":"Can SARS-CoV-2 infection be acquired in utero?: more definitive evidence is needed","author":"Kimberlin","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib11","first-page":"1848","article-title":"Antibodies in infants born to mothers with COVID-19 pneumonia","volume":"323","author":"Zeng","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib12","first-page":"1846","article-title":"Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn","volume":"323","author":"Dong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.0878","article-title":"Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China","author":"Zeng","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajogmf.2020.100159_bib14","first-page":"436","article-title":"[SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF]","volume":"48","author":"Peyronnet","year":"2020","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib15","article-title":"Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia","author":"Chen","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib18","author":"Henao Restrepo"},{"key":"10.1016\/j.ajogmf.2020.100159_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001635","article-title":"Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1\/CO11)","volume":"11","author":"Sibiude","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12879-016-1400-y","article-title":"Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir\/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland","volume":"16","author":"Tookey","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib21","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1073\/pnas.1618029113","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"Retallack","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib22","first-page":"6","article-title":"Azithromycin inhibits the replication of Zika virus","volume":"10","author":"Bosseboeuf","year":"2018","journal-title":"J\u00a0Antivir Antiretrovir"},{"key":"10.1016\/j.ajogmf.2020.100159_bib23","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in\u00a0vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ajogmf.2020.100159_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs","author":"Jeon","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajogmf.2020.100159_bib25","author":"Touret"},{"key":"10.1016\/j.ajogmf.2020.100159_bib26","doi-asserted-by":"crossref","first-page":"812.e1","DOI":"10.1016\/j.ajog.2015.01.015","article-title":"Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis","volume":"212","author":"Sutton","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib27","doi-asserted-by":"crossref","first-page":"m331","DOI":"10.1136\/bmj.m331","article-title":"Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study","volume":"368","author":"Fan","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2020.100159_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1471-0528.2000.tb13339.x","article-title":"The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin","volume":"107","author":"Heikkinen","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2020.100159_bib29","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2012.12.023","article-title":"Safety of macrolides during pregnancy","volume":"208","author":"Lin","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13052-019-0613-2","article-title":"The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis","volume":"45","author":"Almaramhy","year":"2019","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.ajogmf.2020.100159_bib31","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/pds.3900","article-title":"Use of macrolides during pregnancy and the risk of birth defects: a population-based study","volume":"24","author":"B\u00e9rard","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajogmf.2020.100159_bib32","first-page":"101","article-title":"Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis","volume":"100","author":"Cooper","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2125.2008.03111.x","article-title":"Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers","volume":"65","author":"Law","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib34","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","article-title":"Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature","volume":"38","author":"Osadchy","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5935\/0946-5448.20150004","article-title":"Risk of hearing alterations in newborns of mothers treated for malaria","volume":"19","author":"Silva","year":"2015","journal-title":"Int Tinnitus J"},{"key":"10.1016\/j.ajogmf.2020.100159_bib36","first-page":"383","article-title":"Transplacental passage of colchicine in familial Mediterranean fever","volume":"21","author":"Amoura","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib37","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2010.02.063","article-title":"Pregnancy outcome after in utero exposure to colchicine","volume":"203","author":"Diav-Citrin","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/art.10150","article-title":"Evidence of transplacental passage of hydroxychloroquine in humans","volume":"46","author":"Costedoat-Chalumeau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajogmf.2020.100159_bib39","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajogmf.2020.100159_bib40","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/art.20648","article-title":"Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et\u00a0al","volume":"50","author":"Cimaz","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajogmf.2020.100159_bib41","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/AAC.37.6.1232","article-title":"Experimental study of transplacental passage of alpha interferon by two assay techniques","volume":"37","author":"Waysbort","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajogmf.2020.100159_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420910310","article-title":"Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure","volume":"13","author":"Hellwig","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ajogmf.2020.100159_bib43","first-page":"73","article-title":"Study of the transplacental transfer of interferon alfa-2a on the model of isolated perfused cotyledon [in French]","volume":"48","author":"Dumas","year":"1993","journal-title":"Therapie"},{"key":"10.1016\/j.ajogmf.2020.100159_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004536","article-title":"Final results from the Betaseron (interferon \u03b2-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events","volume":"4","author":"Coyle","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajogmf.2020.100159_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000264183","article-title":"Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage","volume":"10","author":"Pons","year":"1995","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajogmf.2020.100159_bib46","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/rheumatology\/kez155","article-title":"Placental transfer of tocilizumab in a patient with rheumatoid arthritis","volume":"58","author":"Tada","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajogmf.2020.100159_bib47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/14397595.2016.1147405","article-title":"Pregnancy outcomes after exposure to tocilizumab: a retrospective analysis of 61 patients in Japan","volume":"26","author":"Nakajima","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2016.05.004","article-title":"Tocilizumab use in pregnancy: analysis of a global safety database including data from clinical trials and post-marketing data","volume":"46","author":"Hoeltzenbein","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ajogmf.2020.100159_bib49","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/rheumatology\/kex305","article-title":"International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors","volume":"56","author":"Youngstein","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajogmf.2020.100159_bib50","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S2214-109X(19)30453-X","article-title":"Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis","volume":"8","author":"Nicolas","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajogmf.2020.100159_bib51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/annrheumdis-2017-212078","article-title":"Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes","volume":"77","author":"B\u00e9rard","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib52","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajog.2006.01.017","article-title":"Placental transfer of lopinavir\/ritonavir in the ex\u00a0vivo human cotyledon perfusion model","volume":"195","author":"Gavard","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib53","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/157016209789973628","article-title":"Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women","volume":"7","author":"Ivanovic","year":"2009","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.ajogmf.2020.100159_bib54","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00002030-200204120-00008","article-title":"Transplacental passage of protease inhibitors at delivery","volume":"16","author":"Marzolini","year":"2002","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.ajogmf.2020.100159_bib55","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1080\/14767058.2016.1211634","article-title":"Transplacental transfer of oseltamivir phosphate and its metabolite oseltamivir carboxylate using the ex\u00a0vivo human placenta perfusion model in Chinese Hans population","volume":"30","author":"Huang","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib56","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12879-018-3423-z","article-title":"Oseltamivir in pregnancy and birth outcomes","volume":"18","author":"Ehrenstein","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib57","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/bdr2.1566","article-title":"Oseltamivir use in pregnancy: risk of birth defects, preterm delivery, and small for gestational age infants","volume":"111","author":"Chambers","year":"2019","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.ajogmf.2020.100159_bib58","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s40264-017-0566-6","article-title":"The Ribavirin Pregnancy Registry: an interim analysis of potential teratogenicity at the mid-point of enrollment","volume":"40","author":"Sinclair","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajogmf.2020.100159_bib59","doi-asserted-by":"crossref","first-page":"619.e1","DOI":"10.1016\/j.ajog.2018.08.041","article-title":"Sildenafil crosses the placenta at therapeutic levels in a dually perfused human cotyledon model","volume":"219","author":"Russo","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000453062","article-title":"Sildenafil in pregnancy: a systematic review of maternal tolerance and obstetric and perinatal outcomes","volume":"41","author":"Dunn","year":"2017","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajogmf.2020.100159_bib61","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s13063-018-2897-8","article-title":"Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I\/IIb placenta transfer and safety study","volume":"19","author":"Russo","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.ajogmf.2020.100159_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219732","article-title":"The effects of sildenafil in maternal and fetal outcomes in pregnancy: a systematic review and meta-analysis","volume":"14","author":"Ferreira","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.ajogmf.2020.100159_bib63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/acsinfecdis.5b00030","article-title":"Evaluation of Ebola virus inhibitors for drug repurposing","volume":"1","author":"Madrid","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijid.2019.01.041","article-title":"Macrolides in critically ill patients with Middle East Respiratory Syndrome","volume":"81","author":"Arabi","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib65","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajogmf.2020.100159_bib67","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1128\/AAC.03721-14","article-title":"Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy","volume":"58","author":"Kemp","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajogmf.2020.100159_bib68","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jit578","article-title":"Transplacental transfer of azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model","volume":"209","author":"Acosta","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-3-39","article-title":"In\u00a0vitro inhibition of human influenza A virus replication by chloroquine","volume":"3","author":"Ooi","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.ajogmf.2020.100159_bib70","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1473-3099(11)70065-2","article-title":"Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial","volume":"11","author":"Paton","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"Savarino","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.ajogmf.2020.100159_bib73","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today\u2019s diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib74","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In\u00a0vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajogmf.2020.100159_bib75","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ajogmf.2020.100159_bib76","doi-asserted-by":"crossref","first-page":"105938","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajogmf.2020.100159_bib77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/hrt.69.5.451","article-title":"Restrictive cardiomyopathy caused by chloroquine","volume":"69","author":"Iglesias Cubero","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.ajogmf.2020.100159_bib78","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3899\/jrheum.110959","article-title":"Cardiomyopathy caused by longterm treatment with chloroquine: a rare disease, or a rare diagnosis?","volume":"39","author":"T\u00f6nnesmann","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ehf2.12276","article-title":"Chloroquine-induced cardiomyopathy: a reversible cause of heart failure","volume":"5","author":"Yogasundaram","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ajogmf.2020.100159_bib80","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/08923973.2013.766801","article-title":"Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement","volume":"35","author":"Vereckei","year":"2013","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib81","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijantimicag.2017.05.011","article-title":"Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling","volume":"50","author":"Salman","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajogmf.2020.100159_bib82","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1128\/AAC.01269-09","article-title":"Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy","volume":"54","author":"Karunajeewa","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajogmf.2020.100159_bib83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000457522","article-title":"Transplacental distribution of chloroquine in sheep","volume":"17","author":"Augustijns","year":"1991","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.ajogmf.2020.100159_bib84","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/clinchem\/28.5.1148","article-title":"Chloroquine and its metabolites in human cord blood, neonatal blood, and urine after maternal medication","volume":"28","author":"Essien","year":"1982","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajogmf.2020.100159_bib85","first-page":"52","article-title":"Prise en charge m\u00e9dicale des personnes vivants avec le VIH. Recommandations du groupe d\u2019experts","volume":"2018","author":"Blanc","year":"2018","journal-title":"D\u00e9sir d\u2019enfant et grossesse"},{"key":"10.1016\/j.ajogmf.2020.100159_bib86","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAD.0000000000002039","article-title":"Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes","volume":"33","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ajogmf.2020.100159_bib87","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1473-3099(11)70339-5","article-title":"Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study","volume":"12","author":"McGready","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib88","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In\u00a0vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib89","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in\u00a0vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ajogmf.2020.100159_bib90","first-page":"249","article-title":"Combating COVID-19 with chloroquine","volume":"12","author":"Hong","year":"2020","journal-title":"J\u00a0Mol Cell Biol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib91","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib92","first-page":"215","article-title":"[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]","volume":"49","author":"Chen","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ajogmf.2020.100159_bib93","author":"Chen"},{"key":"10.1016\/j.ajogmf.2020.100159_bib94","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: an open-label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2020.100159_bib95","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ajogmf.2020.100159_bib96","author":"Mahevas"},{"key":"10.1016\/j.ajogmf.2020.100159_bib97","author":"Mallat"},{"key":"10.1016\/j.ajogmf.2020.100159_bib98","author":"Yu"},{"key":"10.1016\/j.ajogmf.2020.100159_bib99","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0140-6736(20)31324-6","article-title":"Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis [retraction of: Lancet 2020 May 22]","volume":"395","author":"Mehra","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2020.100159_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101738","article-title":"Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France","author":"Million","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib102","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy - implications of research advances for rheumatology care","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib103","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3899\/jrheum.190538","article-title":"Hydroxychloroquine-induced retinal toxicity","volume":"47","author":"Carter","year":"2020","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib104","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajogmf.2020.100159_bib105","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2165\/00002018-200629100-00003","article-title":"Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future","volume":"29","author":"Vroom","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajogmf.2020.100159_bib106","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/14740338.2011.566555","article-title":"Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy","volume":"10","author":"Abarientos","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ajogmf.2020.100159_bib107","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jmv.25729","article-title":"A\u00a0systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-a possible reference for coronavirus disease-19 treatment option","volume":"92","author":"Yao","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib108","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajogmf.2020.100159_bib109","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A\u00a0trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib110","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/cid\/cit390","article-title":"Lopinavir\/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2\/3 randomized trial","volume":"57","author":"Tubiana","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib111","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1128\/AAC.00863-15","article-title":"Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment","volume":"59","author":"Fauchet","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajogmf.2020.100159_bib112","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/bcp.12078","article-title":"Reduced indinavir exposure during pregnancy","volume":"76","author":"Cressey","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib113","doi-asserted-by":"crossref","first-page":"726593","DOI":"10.1155\/2009\/726593","article-title":"Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir\/ritonavir in the ex\u00a0vivo human perfusion model","volume":"2009","author":"Ceccaldi","year":"2009","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ajogmf.2020.100159_bib114","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1128\/AAC.03184-14","article-title":"Placental transfer of darunavir in an ex\u00a0vivo human cotyledon perfusion model","volume":"58","author":"Mandelbrot","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajogmf.2020.100159_bib115","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention","volume":"375","author":"Fowler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib116","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"204","author":"Powis","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib117","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2011.915","article-title":"Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers","volume":"306","author":"Simon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib118","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/v11040326","article-title":"Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir","volume":"11","author":"Tchesnokov","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ajogmf.2020.100159_bib119","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A\u00a0randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib121","doi-asserted-by":"crossref","first-page":"104541","DOI":"10.1016\/j.antiviral.2019.104541","article-title":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase","volume":"169","author":"Brown","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ajogmf.2020.100159_bib122","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib123","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ajogmf.2020.100159_bib124","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - preliminary report","author":"Beigel","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib125","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2020.100159_bib126","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib127","article-title":"Energy Market Authority of Singapore\/204393\/2016, Committee for Medicinal Products for Human Use (CHMP)","year":"2016","journal-title":"Assessment report on Medicinal products under development for the treatment of Ebola"},{"key":"10.1016\/j.ajogmf.2020.100159_bib129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Jin","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ajogmf.2020.100159_bib130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijid.2020.05.085","article-title":"Lack of antiviral activity of darunavir against SARS-CoV-2","volume":"97","author":"De Meyer","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2017.12.021","article-title":"Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus","volume":"151","author":"Bixler","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ajogmf.2020.100159_bib132","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ajogmf.2020.100159_bib133","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.ajogmf.2020.100159_bib134","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ajogmf.2020.100159_bib135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/jiz078","article-title":"Laboratory findings, compassionate use of favipiravir, and outcome in patients With Ebola virus disease, Guinea, 2015-a retrospective observational study","volume":"220","author":"Kerber","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib136","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/v10110610","article-title":"Combination therapy with oseltamivir and favipiravir delays mortality but does not prevent oseltamivir resistance in immunodeficient mice infected with pandemic A(H1N1) influenza virus","volume":"10","author":"Baz","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ajogmf.2020.100159_bib137","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/infdis\/jiz656","article-title":"Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection","volume":"221","author":"Wang","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib138","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib139","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib140","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/cid\/ciz544","article-title":"Ribavirin and interferon therapy for critically ill patients With Middle East respiratory syndrome: a multicenter observational study","volume":"70","author":"Arabi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib141","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/bdra.20682","article-title":"The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003\u20132009","volume":"88","author":"Roberts","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib142","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/cid\/cis198","article-title":"Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?","volume":"54","author":"Sibiude","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib143","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2004.04.083","article-title":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus","volume":"318","author":"Yamamoto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajogmf.2020.100159_bib144","first-page":"9","article-title":"Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures[in Russian]","volume":"53","author":"Khamitov","year":"2008","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib145","first-page":"e1","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against Corona Virus Disease 2019: a retrospective cohort study","volume":"81","author":"Deng","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ajogmf.2020.100159_bib146","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cmi.2020.04.026","article-title":"Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study","volume":"26","author":"Lian","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajogmf.2020.100159_bib147","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1473-3099(20)30176-6","article-title":"Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study","volume":"20","author":"Yu","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib148","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2885.2008.00971.x","article-title":"Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep","volume":"31","author":"P\u00e9rez","year":"2008","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.ajogmf.2020.100159_bib150","first-page":"1715","article-title":"Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European interferon-beta Pregnancy Registry","volume":"267","author":"Hellwig","year":"2020","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib151","doi-asserted-by":"crossref","DOI":"10.1111\/vox.12927","article-title":"Pivotal role of convalescent plasma in managing emerging infectious diseases","author":"Wong","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.ajogmf.2020.100159_bib152","first-page":"152","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","volume":"14","author":"Marano","year":"2016","journal-title":"Blood Transfus"},{"key":"10.1016\/j.ajogmf.2020.100159_bib153","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for Ebola virus disease in guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib154","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.03.039","article-title":"Treatment with convalescent plasma for critically ill patients with Severe Acute Respiratory Syndrome Coronavirus 2 infection","author":"Zhang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.ajogmf.2020.100159_bib156","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ajogmf.2020.100159_bib157","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib158","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/rheumatology\/key091","article-title":"Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study","volume":"57","author":"Saito","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajogmf.2020.100159_bib159","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib160","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s40265-017-0814-1","article-title":"Benefit-risk profile of sphingosine-1-phosphate receptor modulators in relapsing and secondary progressive multiple sclerosis","volume":"77","author":"Comi","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ajogmf.2020.100159_bib161","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12883-017-0794-5","article-title":"Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study","volume":"17","author":"Saida","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib162","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418804760","article-title":"Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure","volume":"11","author":"Geissb\u00fchler","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ajogmf.2020.100159_bib163","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-018-0908-4","article-title":"Baricitinib: a review in rheumatoid arthritis","volume":"78","author":"Al-Salama","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ajogmf.2020.100159_bib164","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X19899296","article-title":"Baricitinib exposure during pregnancy in rheumatoid arthritis","volume":"12","author":"Costanzo","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib165","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17512433.2018.1525293","article-title":"The use of biologics and small molecules in pregnant patients with rheumatic diseases","volume":"11","author":"Gerosa","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib166","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2036.2005.02405.x","article-title":"Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn\u2019s disease","volume":"21","author":"Mahadevan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajogmf.2020.100159_bib167","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","article-title":"Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn","volume":"4","author":"Vasiliauskas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib168","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.crohns.2011.10.002","article-title":"Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31","volume":"6","author":"Steenholdt","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib169","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10067-020-05144-x","article-title":"Colchicine may not be effective in COVID-19 infection; it may even be harmful?","volume":"39","author":"Cumhur Cure","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib170","doi-asserted-by":"crossref","first-page":"102566","DOI":"10.1016\/j.autrev.2020.102566","article-title":"Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: insights from a large healthcare database analysis","volume":"19","author":"Gendelman","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajogmf.2020.100159_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.hjc.2020.03.002","article-title":"The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): rationale and study design","author":"Deftereos","year":"2020","journal-title":"Hell J Cardiol HJC Hell Kardiol Epitheor"},{"key":"10.1016\/j.ajogmf.2020.100159_bib172","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/rheumatology\/kex353","article-title":"Use of colchicine in pregnancy: a systematic review and meta-analysis","volume":"57","author":"Indraratna","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajogmf.2020.100159_bib173","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00563006","article-title":"The placental transfer of betamethasone","volume":"18","author":"Petersen","year":"1980","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib174","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/j.1552-4604.1993.tb01952.x","article-title":"Drug therapy of the fetus","volume":"33","author":"Ward","year":"1993","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/ror.0.0020129","article-title":"Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids","volume":"2","author":"Yang","year":"1997","journal-title":"Rev Reprod"},{"key":"10.1016\/j.ajogmf.2020.100159_bib176","first-page":"CD000065","article-title":"Prophylactic corticosteroids for preterm birth","volume":"2","author":"Crowley","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2020.100159_bib177","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1213\/ANE.0000000000004825","article-title":"Angiotensin II for the treatment of COVID-19-Related vasodilatory shock","volume":"131","author":"Chow","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajogmf.2020.100159_bib178","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1007\/s00018-004-4242-5","article-title":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus","volume":"61","author":"Kuhn","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajogmf.2020.100159_bib179","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bdra.20102","article-title":"Angiotensin II receptor antagonist treatment during pregnancy","volume":"73","author":"Alwan","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib181","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jpeds.2015.05.045","article-title":"Renin angiotensin system blocker fetopathy: a Midwest Pediatric Nephrology Consortium Report","volume":"167","author":"Nadeem","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajogmf.2020.100159_bib182","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1530\/REP-18-0633","article-title":"Dysregulation of the placental renin-angiotensin system in human fetal growth restriction","volume":"158","author":"Delforce","year":"2019","journal-title":"Reproduction"},{"key":"10.1016\/j.ajogmf.2020.100159_bib183","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40272-014-0104-2","article-title":"Ethics of studies of drugs in pregnancy","volume":"17","author":"Matsui","year":"2015","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.ajogmf.2020.100159_bib184","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.2018.17716","article-title":"Increasing the participation of pregnant women in clinical trials","volume":"320","author":"Heyrana","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100159_bib185","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.seizure.2006.08.008","article-title":"The ethics of excluding women who become pregnant while participating in clinical trials of anti-epileptic medications","volume":"15","author":"Beran","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.ajogmf.2020.100159_bib186","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13010-019-0081-8","article-title":"The moral imperative to approve pregnant women\u2019s participation in randomized clinical trials for pregnancy and newborn complications","volume":"14","author":"Kaye","year":"2019","journal-title":"Philos Eth Humanit Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib187","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003088-199528020-00006","article-title":"Models for placental transfer studies of drugs","volume":"28","author":"Bourget","year":"1995","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.ajogmf.2020.100159_bib188","first-page":"S70","article-title":"Drug transporters expressed in the human placenta and models for studying maternal-fetal drug transfer","volume":"59","author":"Dallmann","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib189","article-title":"Clinical effect of mifepristone on patients with ovarian cancer in pregnancy","author":"Shang","year":"2019","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.ajogmf.2020.100159_bib190","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2020.03.015","article-title":"Gynecologic cancer in pregnancy","volume":"157","author":"Korenaga T-RK","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib191","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/jop.2015.0056","article-title":"Intravitreal anti-VEGF injections in pregnancy: case series and review of literature","volume":"31","author":"Polizzi","year":"2015","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajogmf.2020.100159_bib192","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/IAE.0b013e3181f57d58","article-title":"Intravitreal bevacizumab during pregnancy","volume":"30","author":"Tarantola","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.ajogmf.2020.100159_bib193","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tera.1420380303","article-title":"A\u00a0short history of thalidomide embryopathy","volume":"38","author":"Lenz","year":"1988","journal-title":"Teratology"},{"key":"10.1016\/j.ajogmf.2020.100159_bib194","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJM196212062672305","article-title":"The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies","volume":"267","author":"Mellin","year":"1962","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100159_bib195","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tjog.2018.06.020","article-title":"Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: case report and literature review","volume":"57","author":"Nobuhara","year":"2018","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib196","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00404-007-0416-3","article-title":"Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review","volume":"277","author":"Karimi Zarchi","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajogmf.2020.100159_bib197","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.AOG.0000207577.67765.8e","article-title":"Methotrexate, bleomycin, and etoposide in the treatment of gestational trophoblastic neoplasia","volume":"107","author":"Ngan","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib198","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-019-1033-5","article-title":"Requirement for etoposide in the treatment of pregnancy related hemophagocytic lymphohistiocytosis: a multicenter retrospective study","volume":"14","author":"Song","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ajogmf.2020.100159_bib199","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAI.0000000000001963","article-title":"Liver enzyme elevation in pregnant women receiving antiretroviral therapy in the ANRS-French perinatal cohort","volume":"81","author":"Sibiude","year":"2019","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajogmf.2020.100159_bib200","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/QAD.0000000000001681","article-title":"Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model","volume":"32","author":"Faure-Bardon","year":"2018","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.ajogmf.2020.100159_bib201","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2009.08.007","article-title":"Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir","volume":"147","author":"Gavard","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajogmf.2020.100159_bib202","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bcp.12815","article-title":"Prediction of human fetal pharmacokinetics using ex\u00a0vivo human placenta perfusion studies and physiologically based models","volume":"81","author":"De Sousa Mendes","year":"2016","journal-title":"Br J Clin Pharmacol"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933320301038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933320301038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:46:24Z","timestamp":1762904784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933320301038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":197,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2589933320301038"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100159","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100159"}}